Oral Semaglutide
OASIS 1
Novo Nordisk · Phase 3 · Completed · Enrollment 667
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Oral semaglutide | n/r | n/r | n/r | n/r |
| Oral semaglutide placebo | n/r | n/r | n/r | n/r |
Not shown
- Oral semaglutide: endpoint not reported
- Oral semaglutide placebo: endpoint not reported